{"version":"1.0","type":"link","title":"ATOR-4066, a Bispecific Antibody Targeting CD40 and CEACAM5, Induces Strong Myeloid and T Cell-Dependent Tumor Immunity and Synergizes with PD-1 Blockade.","author_name":"Andersson H 외","author_url":"https://prs-insight.online/author/Andersson%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/169833","thumbnail_width":1200,"thumbnail_height":630}